A 46-year-old G2P2 woman presents to the clinic with a 5-month history of heavy, irregular vaginal bleeding. She reports her menstrual periods occur unpredictably every 18 to 40 days, lasting up to 10 days, with the passage of large clots. She has a history of type 2 diabetes mellitus and hypertension. Her body mass index is . Vital signs are stable. Pelvic examination reveals a normal-appearing cervix and a bulky, mobile uterus. Arrange the following steps in the most appropriate chronological order for the evaluation and management of this patient's abnormal uterine bleeding, assuming benign initial findings and a desire to avoid surgery if possible.
- 1Measurement of urine beta-hCG
- 2Endometrial biopsy
- 3Initiation of a levonorgestrel-releasing intrauterine device
- 4Definitive surgical management (e.g., hysterectomy)
Cevap
The correct chronological sequence is: Measurement of urine beta-hCG, followed by Endometrial biopsy, then Initiation of a levonorgestrel-releasing intrauterine device, and finally Definitive surgical management if medical therapy fails.
The evaluation of abnormal uterine bleeding follows a strict algorithmic approach. The very first step in any reproductive-age woman is to rule out pregnancy with a beta-hCG test. Once pregnancy is excluded, the patient's age and risk factors dictate the next step. For a 46-year-old with obesity and diabetes, endometrial biopsy is mandatory to evaluate for endometrial hyperplasia or malignancy. Assuming a benign biopsy, first-line therapy is medical, utilizing options like the levonorgestrel-releasing IUD to thin the endometrium and reduce bleeding. If medical therapy fails to control symptoms, definitive surgical management such as a hysterectomy becomes the final step in the sequence.
Adım Adım Çözüm
Anahtar Kavram
The stepwise evaluation of abnormal uterine bleeding prioritizes ruling out pregnancy, followed by ruling out malignancy in high-risk patients, before proceeding to medical management and lastly surgical intervention.